Ticker LaunchSPAC · Liquidated
Ibere Pharmaceuticals
Ibere Pharmaceuticals is a blank-check company (SPAC) that raised $120M in its initial public offering on Mar 1, 2021, listing on New York Stock Exchange. It did not complete a business combination and liquidated around Mar 2, 2023, returning the trust to public shareholders. A&O Shearman advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Mar 1, 2021
- IPO size
- $120M
- IPO exchange
- New York Stock Exchange
- SPAC counsel (IPO)
- A&O Shearman and Walkers
- Underwriters' counsel (IPO)
- Ellenoff Grossman & Schole
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Mar 1, 2021
- All filings on EDGAR CIK 1835205
Other SPAC IPOs from 2021
- Twelve Seas Investment Co. IIMar 1, 2021
- African Gold Acquisition CorpMar 1, 2021
- SilverBox Engaged Merger Corp IMar 1, 2021 · $300M
- Austerlitz Acquisition Corp IMar 1, 2021 · $600M
- ARYA Sciences Acquisition Corp IVMar 1, 2021 · $130M
- Freedom Acquisition I Corp.Mar 1, 2021 · $300M